Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$601M |
| 2 |
Moderna
MRNA
|
+$557M |
| 3 |
Analog Devices
ADI
|
+$448M |
| 4 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$445M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$406M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$652M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$512M |
| 3 |
TSMC
TSM
|
+$378M |
| 4 |
JPMorgan Chase
JPM
|
+$318M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNS
3201
DELISTED
WNS Holdings
WNS
| $2.35M | ﹤0.01% |
28,763
-7,055
| -20% | -$577K |
|
3202
Evolus
EOLS
$385M
| $2.35M | ﹤0.01% |
308,290
-34,483
| -10% | -$357K |
|
|
LENZ
3203
LENZ Therapeutics
LENZ
$166M
| $2.35M | ﹤0.01% |
+20,457
| New | +$3.03M |
|
|
SCPL
3204
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $2.35M | ﹤0.01% |
113,433
+6,111
| +6% | +$108K |
|
|
SYRS
3205
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.35M | ﹤0.01% |
52,468
-2,974
| -5% | -$145K |
|
3206
Limoneira
LMNR
$235M
| $2.34M | ﹤0.01% |
144,978
-8,027
| -5% | -$135K |
|
3207
Radiant Logistics
RLGT
$386M
| $2.33M | ﹤0.01% |
364,817
-15,870
| -4% | -$102K |
|
|
DAWN
3208
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.33M | ﹤0.01% |
98,099
+85,381
| +671% | +$2.05M |
|
|
PCSB
3209
DELISTED
PCSB Financial Corporation
PCSB
| $2.33M | ﹤0.01% |
126,126
-919
| -0.7% | -$16.8K |
|
|
HBMD
3210
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $2.33M | ﹤0.01% |
114,719
-5,808
| -5% | -$111K |
|
|
INST
3211
DELISTED
Instructure Holdings, Inc.
INST
| $2.32M | ﹤0.01% |
+102,821
| New | +$2.19M |
|
3212
Pure Cycle
PCYO
$253M
| $2.32M | ﹤0.01% |
174,443
-24,034
| -12% | -$348K |
|
3213
Monte Rosa Therapeutics
GLUE
$1.4B
| $2.32M | ﹤0.01% |
+103,997
| New | +$2.98M |
|
3214
Orrstown Financial Services
ORRF
$840M
| $2.32M | ﹤0.01% |
99,021
-4,404
| -4% | -$102K |
|
|
URG
3215
Ur-Energy
URG
$485M
| $2.32M | ﹤0.01% |
1,346,811
-80,644
| -6% | -$108K |
|
|
DOMA
3216
DELISTED
Doma Holdings, Inc.
DOMA
| $2.29M | ﹤0.01% |
+12,373
| New | +$2.59M |
|
|
CDAK
3217
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $2.29M | ﹤0.01% |
140,046
-1,820
| -1% | -$32.6K |
|
3218
Banco de Chile
BCH
$20.9B
| $2.29M | ﹤0.01% |
123,617
-28,524
| -19% | -$529K |
|
|
EIGR
3219
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.29M | ﹤0.01% |
11,402
-436
| -4% | -$104K |
|
|
HOLI
3220
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.27M | ﹤0.01% |
109,977
-1,004
| -0.9% | -$18.4K |
|
3221
Retractable Technologies
RVP
$19.8M
| $2.27M | ﹤0.01% |
206,178
+20,745
| +11% | +$243K |
|
|
PRTK
3222
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.27M | ﹤0.01% |
466,871
-14,191
| -3% | -$78.2K |
|
3223
Nature's Sunshine
NATR
$354M
| $2.27M | ﹤0.01% |
154,755
-12,445
| -7% | -$209K |
|
3224
Sight Sciences
SGHT
$286M
| $2.26M | ﹤0.01% |
+99,753
| New | +$3.28M |
|
3225
Safe Bulkers
SB
$795M
| $2.26M | ﹤0.01% |
437,685
+13,510
| +3% | +$52.1K |
|
Similar funds
Northern Trust's Q3 2021 Portfolio in Review
As of Q3 2021, Northern Trust held 4,828 positions worth $565B, down 0.48% from $568B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Northern Trust's Q3 2021 filing shows 242 new, 1,428 increased, 2,705 reduced and 176 closed positions. Its largest new stake was Dimensional International Value ETF: 4,656,805 shares worth $152M. The largest sale was Alphabet (Google) Class C, an estimated $652M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q3 2021 buy was Dimensional International Value ETF: 4,656,805 shares worth $152M.
- Northern Trust added most to Johnson & Johnson in Q3 2021, an estimated $601M increase.
- Northern Trust's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $652M.
- Northern Trust fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $512M.
- Northern Trust's ten largest holdings make up 22% of its $565B portfolio in Q3 2021.
- Northern Trust opened 242 new positions and closed 176 in Q3 2021.
- Northern Trust's portfolio value fell 0.48% quarter-over-quarter to $565B.
Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.